William S. Dalton
- Molecular Biology top 0.5%
- Oncology top 0.2%
- Hematology top 0.2%
- Cancer Research top 0.5%
- Immunology top 1%
- Co-authors
- Terry H. LandowskiLori HazlehurstKenneth H. ShainRichard JoveMark B. MeadsRobert A. GatenbyLynn C. MoscinskiDomenico Coppola
- Topics
- Multiple Myeloma Research and Treatments (44 papers)Drug Transport and Resistance Mechanisms (21 papers)Cancer therapeutics and mechanisms (21 papers)
- Cited by
- HematologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Investigation
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
William S. Dalton
130 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Molecular Biology 6.8k
- Oncology 5.7k
- Hematology 2.4k
- Cancer Research 2.3k
- Immunology 2.3k
Countries citing papers authored by William S. Dalton
This map shows the geographic impact of William S. Dalton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William S. Dalton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William S. Dalton more than expected).
Fields of papers citing papers by William S. Dalton
This network shows the impact of papers produced by William S. Dalton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William S. Dalton. The network helps show where William S. Dalton may publish in the future.
Co-authorship network of co-authors of William S. Dalton
This figure shows the co-authorship network connecting the top 25 collaborators of William S. Dalton. A scholar is included among the top collaborators of William S. Dalton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William S. Dalton. William S. Dalton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 69 | |
| 3 | 90 | |
| 4 | 33 | |
| 5 | 23 | |
| 6 | Bone marrow stromal cells activate Stat3 and confer resistance to Bcr-Abl inhibitors in K562 CML cells | 0 |
| 7 | 37 | |
| 8 | 114 | |
| 9 | 30 | |
| 10 | Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cellsbreakdown → | 923 |
| 11 | 162 | |
| 12 | 132 | |
| 13 | 284 | |
| 14 | Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cellsbreakdown → | 1408 |
| 15 | 192 | |
| 16 | 22 | |
| 17 | 15 | |
| 18 | 69 | |
| 19 | 20 | |
| 20 | Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. | 25 |
About William S. Dalton
William S. Dalton is a scholar working on Hematology, Oncology and Immunology and Allergy, having authored 132 papers that have together received 11.8k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (44 papers), Drug Transport and Resistance Mechanisms (21 papers) and Cancer therapeutics and mechanisms (21 papers). The work is most often cited by research in Hematology (2.4k citations), Oncology (5.7k citations) and Cancer Research (2.3k citations). William S. Dalton has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Terry H. Landowski, Lori Hazlehurst, Kenneth H. Shain, Richard Jove, Mark B. Meads, Robert A. Gatenby, Lynn C. Moscinski, Domenico Coppola, Marc M. Oshiro and Robyn Catlett-Falcone. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.